(Q39845849)

15 September 2017

title

Released intranasal eosinophilic major basic protein as a diagnostic marker for polypoid chronic rhinosinusitis (English)

1 reference

15 September 2017

1 reference

1 reference

Christoph Schmid

1

1 reference

15 September 2017

Walter Habermann

2

1 reference

15 September 2017

Hannes Braun

3

1 reference

15 September 2017

Markus Gugatschka

4

1 reference

15 September 2017

Brad S Oriel

5

1 reference

15 September 2017

Janel A Smietana

6

1 reference

15 September 2017

Heinz Stammberger

7

1 reference

15 September 2017

publication date

1 September 2010

1 reference

Otolaryngology—Head and Neck Surgery

15 September 2017

published in

1 reference

15 September 2017

volume

143

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

386-391

1 reference

Staphylococcus aureus superantigens and airway disease

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2010.05.017

'Eosinophilic fungal rhinosinusitis': a common disorder in Europe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2010.05.017

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2010.05.017

Striking deposition of toxic eosinophil major basic protein in mucus: implications for chronic rhinosinusitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2010.05.017

Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2010.05.017

Effects of glucocorticoids on infiltrating cells and epithelial cells of nasal polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2010.05.017

Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2010.05.017

Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2010.05.017

The eosinophil and the pathophysiology of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2010.05.017

Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2010.05.017

10.1016/J.OTOHNS.2010.05.017

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference